The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Onconova Therapeutics, Inc. - Phase 3 Clinical-stage Biopharmaceutical Company Discusses Target Indications and Clinical Development

SNNLive spoke with Ramesh Kumar, President & CEO of Onconova Therapeutics, Inc. (NASDAQ: ONTX) at the LD Micro "Main Event" 2016 in Bel Air, CA.

Share With

Tuesday, January 10, 2017

   

© 2017 Stock News Now